Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown-Reference-Cited by-同舟云学术

Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown

Published:2020-07-01 Issue:7 Volume:22 Page:527-534
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Anjana Ranjit Mohan¹,Pradeepa Rajendra¹,Deepa Mohan¹,Jebarani Saravanan¹,Venkatesan Ulagamathesan¹,Parvathi Somasundaram Jaya¹,Balasubramanyam Muthuswamy¹,Radha Venkatesan¹,Poongothai Subramani¹,Sudha Vasudevan¹,Shanthi Rani Coimbatore Subramanian¹,Ranjani Harish¹,Amutha Anandakumar¹,Manickam Nagaraj¹,Unnikrishnan Ranjit¹,Mohan Viswanathan¹

Affiliation:

1. Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, Chennai, India.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2020.0240

Reference8 articles.

1. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

2. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

3. Use of Telemedicine Technologies in Diabetes Prevention and Control in Resource-Constrained Settings: Lessons Learned from Emerging Economies